BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7612954)

  • 1. The identity of proliferating cells in bone tumors with cartilaginous components: evaluation by double-immunohistochemical staining using proliferating cell nuclear antigen and S-100 protein.
    Chano T; Ishizawa M; Matsumoto K; Morimoto S; Hukuda S; Okabe H
    Eur J Histochem; 1995; 39(1):21-30. PubMed ID: 7612954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
    Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
    Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
    Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
    Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periosteal osteosarcoma and parosteal chondrosarcoma evaluated by double immunohistochemical staining. Report of 2 cases.
    Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H
    Acta Orthop Scand; 1994 Jun; 65(3):355-8. PubMed ID: 7518993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cytomorphological scheme of differentiating neuronal phenotypes in cerebellar medulloblastomas based on immunolocalization of class III beta-tubulin isotype (beta III) and proliferating cell nuclear antigen (PCNA)/cyclin.
    Katsetos CD; Krishna L; Frankfurter A; Karkavelas G; Wolfe DE; Valsamis MP; Schiffer D; Vlachos IN; Urich H
    Clin Neuropathol; 1995; 14(2):72-81. PubMed ID: 7606900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological analysis, immunohistochemical study and electron microscopic observation of chondroblastoma of bone].
    Wang LT
    Zhonghua Wai Ke Za Zhi; 1993 Dec; 31(12):717-21. PubMed ID: 8033700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
    Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
    Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
    Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
    Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of proliferating cell nuclear antigen (PCNA) expression in brain tumors].
    Honjho Y; Fujiwara T; Nagao S; Tuchida T
    No Shinkei Geka; 1996 Feb; 24(2):143-8. PubMed ID: 8849474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
    Zhou G; Lin D; Liang C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical phenotyping and PCNA detection in gastrointestinal stromal tumors.
    Vrettou E; Karkavelas G; Christoforidou B; Meditskou S; Papadimitriou CS
    Anticancer Res; 1995; 15(3):943-9. PubMed ID: 7645984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
    Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
    Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
    Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
    Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of immunohistochemistry as a diagnostic tool for tumors and pseudotumoral bone lesions].
    Ushigome S; Nikaido T; Masui F
    Ann Pathol; 2001 Dec; 21(6):460-7. PubMed ID: 11910933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.